3136 results for «2049»

Filter By

3136 results

EuroPCR 2022 Hotlines / Late-Breaking Trials in TAVI: TRANSIT-PPM, LYTEN, SCOPE 2, and more!

18 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in TAVI! Balloon vs. self-expanding valves in valve-in-valve TAVI, trilogy for treatment of aortic regurgitation, management of Myocardial Revascularization in Patients with Stable Coronary Artery Disease Undergoing TAVI, SCOPE 2 subanalysis, prosthesis-patient mismatch following TAVR, and stroke complicating...

EuroPCR 2022 Hotlines / Late-Breaking Trials in TAVI: TRANSIT-PPM, LYTEN, SCOPE 2, and more!

Innovations in simulation-based training, procedural planning, monitoring and robotic PCI

17 May 2022 – From EuroPCR 2022

In this session, find out more about telemedicine, mixed reality technology in CTO proctoring, new-human grade simulator for ViV procedure planning, distance proctoring for transseptal TMVR, stent positioning assistance system, and robotic PCI.

Innovations in simulation-based training, procedural planning, monitoring and robotic PCI

Innovations in coronary physiology

18 May 2022 – From EuroPCR 2022

Watch this EuroPCR 2022 session to compare diagnostic accuracy of one versus two angiographic views, study normal and ANOCA patients, and find out more about a novel approach to manage coronary microvascular dysfunction.

Innovations in coronary physiology

EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!

19 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in drug-eluting balloons! A Sirolimus-coated balloon with micro-reservoir technology in coronary lesions, utilisation of DEB guided by post-PCI pressure gradient, DEB in combination with DES in the treatment of diffuse coronary artery disease,DEB for in-stent restenosis and plaque...

EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!

PCR Innovators Day - innovations in imaging and physiology

18 May 2022 – From EuroPCR 2022

Find out more about the first in-vivo measurements of coronary flow by an optical tagging microcatheter, the development of an early clinical experience with hybrid IVUS and OCT, and the first animal experience as for intracoronary physiology in this EuroPCR 2022 session.

PCR Innovators Day - innovations in imaging and physiology

PCR Innovators Day - Innovations for valve treatment: new devices, new tools, new procedures

19 May 2022 – From EuroPCR 2022

Valvular heart disease is probably one of the most innovative areas in cardiovascular medicine at large: tremendous progress has been made both in terms of quality of life and mortality. Technology continues to evolve, as there are still many gaps to be filled, and it is...

PCR Innovators Day - Innovations for valve treatment: new devices, new tools, new procedures

The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis

18 May 2022 – From EUROPCR 2022

This session from EuroPCR 2022 will help you understand how the first bioprosthetic aortic valve may affect long-term outcomes of patients with aortic stenosis. Learn how to optimise their lifetime management and how to refine procedural steps during TAVI.

The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis

Tailored support for complex PCI and AMI with percutaneous mechanical circulatory support

17 May 2022 – From EuroPCR 2022

Watch this EuroPCR 2022 session, in which Javier Escaned, Florim Cuculi, and Norman Mangner present different cases, to learn how standard operating procedures including mechanical circulatory support improve outcomes in patients with complex coronary lesions, discuss new strategies to overcome ischemic reperfusion lesions using percutaneous mechanical circulatory support,...

Tailored support for complex PCI and AMI with percutaneous mechanical circulatory support

Is DK Crush the optimal two-stent bifurcation strategy for left main PCI?

17 May 2022 – From EuroPCR 2022

In this EuroPCR 2022 session, follow the discussion around the recorded case of a 67-year-old non-smoking male patient who presented with chest pain on exertion typical of angina for one month, and learn how to optimally treat a severely calcified long lesion, understand how imaging can...

Is DK Crush the optimal two-stent bifurcation strategy for left main PCI?

Double jeopardy: coronary disease in patients undergoing TAVI

17 May 2022 – From EuroPCR 2022

Through the presentation of real-life clinical cases, this session will allow you to discover the use of ALLEGRA for valve-in-valve TAVI, understand the management of coronary artery disease in TAVI patients, better detect when and how to protect coronary arteries during TAVI, or even learn how...

Double jeopardy: coronary disease in patients undergoing TAVI

How to deal with calcified CTO

17 May 2022 – From EuroPCR 2022

In this dedicated session from EuroPCR 2022, listen to Gabriele Luigi Gasparini talk about procedural challenges and device selection for calcified CTO, while James Spratt looks at how to deal with long, calcified CTO, and Kambis Mashayekhi discusses problems and solutions in calcified CTO.

How to deal with calcified CTO

Leading clinical evidence while disrupting the mitral paradigm with clip therapy

17 May 2022 – From EuroPCR 2022

Watch this EuroPCR 2022 session with Nicole Karam, Stephan Baldus, Fabien Praz, Wolfgang Rottbauer, and Martin Swaans, and learn how the recent guidelines change the game in mitral disease management, how they can be implemented in practice, and what are the latest real-life clip data and...

Leading clinical evidence while disrupting the mitral paradigm with clip therapy

Advances in renal denervation: from patient selection to procedure

17 May 2022 – From EuroPCR 2022

For this EuroPCR 2022 session, Felix Mahfoud is joined by David Kandzari, Rasha Al-Lamee, Flavio Ribichini, and Andrew Sharp to talk about renal denervation: hear real-life experiences and get the latest preclinical and clinical data on the long-term safety and efficacy of the radiofrequency renal denervation...

Advances in renal denervation: from patient selection to procedure

Valve-in-valve: the journey starts with the first prosthesis

17 May 2022 – From EuroPCR 2022

In this EuroPCR 2022 session featuring Philip Maccarthy, Julia Mascherbauer, Hendrik Treede, Christian Hengstenberg, Radoslaw Parma, and Giuseppe Tarantini, analyze the impact of valve-in-valve interventions on lifetime management, learn about particular clinical considerations and the procedural technique of TAVI-in-TAVI procedures, and appreciate the potential pitfalls of...

Valve-in-valve: the journey starts with the first prosthesis

The cathlab of the future

17 May 2022 – From EuroPCR 2022

Let's take the practical case of an 84-year-old male patient with hypertension, dyslipidaemia, and severe aortic stenosis: in this EuroPCR 2022 session, find out how to treat such a patient in the cathlab of the future and discuss the benefits of non-invasive technology at tableside, tools...

The cathlab of the future

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation

Towards a personalised coronary intervention with CT-guided robotic-assisted PCI

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session aims to show how coronary CT angiography can help in pre-procedural planning and guidance of PCI to achieve the best patient outcomes. It also explores the role of robotic-assisted PCI in improving procedural accuracy, radiation safety, and ergonomics within the cathlab. Finally, it demonstrates how...

Towards a personalised coronary intervention with CT-guided robotic-assisted PCI

Start treating refractory angina patients with Reducer therapy - Practical aspects

17 May 2022 – From EuroPCR 2022

Looking at a 75-year-old male patient with HTA, diabetes, and hypothyroidism, a history of coronary artery disease treated with PCI of the RCA, and a previous coronary angiography showing preserved LVEF and in-stent restenosis of the RCA, you will learn in this EuroPCR 2022 session how...

Start treating refractory angina patients with Reducer therapy - Practical aspects

DCB and the possibility of a clean vessel

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session aims to show, based on real-life cases, that even complex coronary disease can be treated without the need for permanent coronary stents. Learn how to prepare the vessel, deliver the therapy, and assess immediate outcomes after "DCB-alone" PCI, discuss de novo, small vessels, and...

DCB and the possibility of a clean vessel

2022: a tipping point in the treatment of mitral regurgitation patients

17 May 2022 – From EuroPCR 2022

With study outcomes and clinical cases, this EuroPCR 2022 session will enable you to discuss the anatomical considerations that define suitable candidates for treatment of mitral regurgitation with the PASCAL platform and highlight key differentiators and tips and tricks for its use.

2022: a tipping point in the treatment of mitral regurgitation patients
Didn’t find what you were looking for?